Ignite Creation Date:
2025-12-24 @ 2:39 PM
Ignite Modification Date:
2026-02-03 @ 5:14 AM
Study NCT ID:
NCT05279859
Status:
WITHDRAWN
Last Update Posted:
2022-06-15
First Post:
2022-03-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Anti-Cancer Therapies Targeting the MAPK Pathway in Patients With Hematologic Malignancies
Sponsor:
Erasca, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Acute Myeloid Leukemia | View |